- Home
- CHEK vs GCTK Comparison
CHEK vs GCTK Comparison
Compare CHEK & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- GCTK
- Stock Information
- Founded
- CHEK 2004
- GCTK 2001
- Country
- CHEK Israel
- GCTK United States
- Employees
- CHEK N/A
- GCTK N/A
- Industry
- CHEK Medical Electronics
- GCTK Medical/Dental Instruments
- Sector
- CHEK Health Care
- GCTK Health Care
- Exchange
- CHEK Nasdaq
- GCTK Nasdaq
- Market Cap
- CHEK 4.5M
- GCTK 3.7M
- IPO Year
- CHEK 2015
- GCTK N/A
- Fundamental
- Price
- CHEK $0.73
- GCTK $6.56
- Analyst Decision
- CHEK
- GCTK
- Analyst Count
- CHEK 0
- GCTK 0
- Target Price
- CHEK N/A
- GCTK N/A
- AVG Volume (30 Days)
- CHEK 34.0K
- GCTK 1.2M
- Earning Date
- CHEK 08-14-2025
- GCTK 08-12-2025
- Dividend Yield
- CHEK N/A
- GCTK N/A
- EPS Growth
- CHEK N/A
- GCTK N/A
- EPS
- CHEK N/A
- GCTK N/A
- Revenue
- CHEK N/A
- GCTK N/A
- Revenue This Year
- CHEK N/A
- GCTK N/A
- Revenue Next Year
- CHEK N/A
- GCTK N/A
- P/E Ratio
- CHEK N/A
- GCTK N/A
- Revenue Growth
- CHEK N/A
- GCTK N/A
- 52 Week Low
- CHEK $0.56
- GCTK $5.11
- 52 Week High
- CHEK $3.04
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- CHEK 41.33
- GCTK 49.86
- Support Level
- CHEK $0.73
- GCTK $6.85
- Resistance Level
- CHEK $0.80
- GCTK $8.85
- Average True Range (ATR)
- CHEK 0.02
- GCTK 0.73
- MACD
- CHEK -0.00
- GCTK 0.19
- Stochastic Oscillator
- CHEK 14.29
- GCTK 37.60
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.